This grant offered by the National Institute of Allergy and Infectious Diseases aims to support multidisciplinary teams in understanding the mechanisms affecting resistance to HIV broadly neutralizing antibodies (bNAbs). Researchers are encouraged to develop strategies to prevent and overcome HIV resistance to bNAbs. Applications close on July 30, 2021.
Opportunity ID: 332448
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-AI-21-009 |
| Funding Opportunity Title: | Mechanisms of HIV Resistance to Broadly Neutralizing Antibodies (bNAbs) (U01 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.855 — Allergy and Infectious Diseases Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Mar 30, 2021 |
| Last Updated Date: | Mar 30, 2021 |
| Original Closing Date for Applications: | Jul 30, 2021 |
| Current Closing Date for Applications: | Jul 30, 2021 |
| Archive Date: | Sep 04, 2021 |
| Estimated Total Program Funding: | $2,500,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) Independent school districts Native American tribal governments (Federally recognized) Native American tribal organizations (other than Federally recognized tribal governments) Small businesses Public and State controlled institutions of higher education Private institutions of higher education Public housing authorities/Indian housing authorities County governments State governments Special district governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses City or township governments |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | To encourage multidisciplinary teams to characterize mechanisms that impact resistance to HIV broadly neutralizing antibodies (bNAbs) and develop strategies to prevent and overcome HIV resistance to bNAbs. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-21-009.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-F | Use for due dates on or after May 25, 2020 | PKG00266245 | Jun 30, 2021 | Jul 30, 2021 | View |
Package 1
Mandatory forms
332448 RR_SF424_2_0-2.0.pdf
332448 PHS398_CoverPageSupplement_5_0-5.0.pdf
332448 RR_OtherProjectInfo_1_4-1.4.pdf
332448 PerformanceSite_2_0-2.0.pdf
332448 RR_KeyPersonExpanded_2_0-2.0.pdf
332448 PHS398_ResearchPlan_4_0-4.0.pdf
332448 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
332448 RR_Budget_1_4-1.4.pdf
332448 RR_SubawardBudget30_1_4-1.4.pdf
332448 PHS398_ModularBudget_1_2-1.2.pdf
332448 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
